TENOFOVIR DISOPROXIL fumarate 300mg, eq. 245mg base, tab.
STD
DORATENO3T-
Valid Article
Account code:
60000
HS Code:
300490
Last Updated on:
28/01/2026, 22:01:55
Former
Code(s):
-X DORAZBD0426
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
Classification of the medicines in groups and subgroups according to their therapeutic use.
The classification used by MSF is based on the WHO Model List of Essential Medicines.
J05AF07
Anatomical Therapeutic Chemical Classification according to WHOCC
Thermosensitive codes are defined for storage and transportation temperature requirements of the products.
TENOFOVIR (TDF)
Therapeutic Action
Antiretroviral, nucleotide reverse transcriptase inhibitor (NRTI)
Indications
Chronic hepatitis B virus (HBV) infection in adults and adolescents from 12 years of age for whom antiviral therapy is indicated.
For HIV treatment, use fixed-dose combination containing tenofovir in combination with other ARVs.
Instructions for use
For the treatment of HBV in children aged 2 to 12 years, entecavir (ETV), another antiretroviral NRTI, is recommended as first-line treatment.
Precautions for Use
Closely monitor renal function.
Storage
Below 25ºC